Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys and tenofovir in chronic hepatitis D
NCT01088659Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2010
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir in chronic hepatitis D, sponsored by Roche. Started Feb 2010; status: completed.
02
Drugs
tenofovir
03
Conditions
chronic hepatitis D
Beyond the preview
Go deeper on NCT01088659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088659.